Table of Content

1 Study Coverage
1.1 End Stage Renal Disease Drug Product Introduction
1.2 Global End Stage Renal Disease Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global End Stage Renal Disease Drug Sales in US$ Million for the Year 2018-2034
1.2.2 Global End Stage Renal Disease Drug Sales in Volume for the Year 2018-2034
1.3 India End Stage Renal Disease Drug Outlook 2018 VS 2024 VS 2034
1.3.1 India End Stage Renal Disease Drug Sales in US$ Million for the Year 2018-2034
1.3.2 India End Stage Renal Disease Drug Sales in Volume for the Year 2018-2034
1.4 End Stage Renal Disease Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India End Stage Renal Disease Drug in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of End Stage Renal Disease Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 End Stage Renal Disease Drug Market Dynamics
1.5.1 End Stage Renal Disease Drug Industry Trends
1.5.2 End Stage Renal Disease Drug Market Drivers
1.5.3 End Stage Renal Disease Drug Market Challenges
1.5.4 End Stage Renal Disease Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 End Stage Renal Disease Drug by Type
2.1 End Stage Renal Disease Drug Market Segment by Type
2.1.1 Calcimimetics
2.1.2 Vitamin D
2.1.3 Sterols
2.1.4 Potassium Binders
2.1.5 Calcium-Based Phosphate Binders
2.1.6 Other
2.2 Global End Stage Renal Disease Drug Market Size by Type
2.2.1 Global End Stage Renal Disease Drug Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global End Stage Renal Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global End Stage Renal Disease Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India End Stage Renal Disease Drug Market Size by Type
2.3.1 India End Stage Renal Disease Drug Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India End Stage Renal Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India End Stage Renal Disease Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 End Stage Renal Disease Drug by Application
3.1 End Stage Renal Disease Drug Market Segment by Application
3.1.1 End Stage Renal Disease Induced Hyperparathyroidism
3.1.2 End Stage Renal Disease Induced Hyperphosphatemia
3.1.3 End Stage Renal Disease Induced Hyperkalaemia
3.2 Global End Stage Renal Disease Drug Market Size by Application
3.2.1 Global End Stage Renal Disease Drug Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global End Stage Renal Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global End Stage Renal Disease Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India End Stage Renal Disease Drug Market Size by Application
3.3.1 India End Stage Renal Disease Drug Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India End Stage Renal Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India End Stage Renal Disease Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global End Stage Renal Disease Drug Competitor Landscape by Company
4.1 Global End Stage Renal Disease Drug Market Size by Company
4.1.1 Global Key Manufacturers of End Stage Renal Disease Drug, Ranked by Revenue (2024)
4.1.2 Global End Stage Renal Disease Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global End Stage Renal Disease Drug Sales by Manufacturer (2018-2023)
4.1.4 Global End Stage Renal Disease Drug Price by Manufacturer (2018-2023)
4.2 Global End Stage Renal Disease Drug Concentration Ratio (CR)
4.2.1 End Stage Renal Disease Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of End Stage Renal Disease Drug in 2024
4.2.3 Global End Stage Renal Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of End Stage Renal Disease Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of End Stage Renal Disease Drug, Product Offered and Application
4.5 Global Key Manufacturers of End Stage Renal Disease Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India End Stage Renal Disease Drug Market Size by Company
4.7.1 Key Players of End Stage Renal Disease Drug in India, Ranked by Revenue (2024)
4.7.2 India End Stage Renal Disease Drug Revenue by Players (2018-2023)
4.7.3 India End Stage Renal Disease Drug Sales by Players (2018-2023)
5 Global End Stage Renal Disease Drug Market Size by Region
5.1 Global End Stage Renal Disease Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global End Stage Renal Disease Drug Market Size in Volume by Region (2018-2034)
5.2.1 Global End Stage Renal Disease Drug Sales in Volume by Region: 2018-2023
5.2.2 Global End Stage Renal Disease Drug Sales in Volume Forecast by Region (2024-2034)
5.3 Global End Stage Renal Disease Drug Market Size in Value by Region (2018-2034)
5.3.1 Global End Stage Renal Disease Drug Sales in Value by Region: 2018-2023
5.3.2 Global End Stage Renal Disease Drug Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas End Stage Renal Disease Drug Market Size YoY Growth 2018-2034
6.2 Americas End Stage Renal Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas End Stage Renal Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas End Stage Renal Disease Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas End Stage Renal Disease Drug Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas End Stage Renal Disease Drug Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA End Stage Renal Disease Drug Market Size YoY Growth 2018-2034
7.2 EMEA End Stage Renal Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA End Stage Renal Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA End Stage Renal Disease Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA End Stage Renal Disease Drug Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA End Stage Renal Disease Drug Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China End Stage Renal Disease Drug Market Size YoY Growth 2018-2034
8.2 China End Stage Renal Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China End Stage Renal Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC End Stage Renal Disease Drug Market Size YoY Growth 2018-2034
9.2 APAC End Stage Renal Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC End Stage Renal Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC End Stage Renal Disease Drug Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC End Stage Renal Disease Drug Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC End Stage Renal Disease Drug Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information
10.1.2 Pfizer Inc Description and Business Overview
10.1.3 Pfizer Inc End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Inc End Stage Renal Disease Drug Products Offered
10.1.5 Pfizer Inc Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Description and Business Overview
10.2.3 AstraZeneca End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca End Stage Renal Disease Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Information
10.3.2 Bristol-Myers Squibb Company Description and Business Overview
10.3.3 Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bristol-Myers Squibb Company End Stage Renal Disease Drug Products Offered
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 Dr. Reddy's Laboratories Ltd
10.4.1 Dr. Reddy's Laboratories Ltd Company Information
10.4.2 Dr. Reddy's Laboratories Ltd Description and Business Overview
10.4.3 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Products Offered
10.4.5 Dr. Reddy's Laboratories Ltd Recent Development
10.5 Endo International plc
10.5.1 Endo International plc Company Information
10.5.2 Endo International plc Description and Business Overview
10.5.3 Endo International plc End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Endo International plc End Stage Renal Disease Drug Products Offered
10.5.5 Endo International plc Recent Development
10.6 Teva Pharmaceutical Industries Ltd
10.6.1 Teva Pharmaceutical Industries Ltd Company Information
10.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
10.6.3 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Products Offered
10.6.5 Teva Pharmaceutical Industries Ltd Recent Development
10.7 Sun Pharmaceutical Industries Ltd
10.7.1 Sun Pharmaceutical Industries Ltd Company Information
10.7.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
10.7.3 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Products Offered
10.7.5 Sun Pharmaceutical Industries Ltd Recent Development
10.8 Mylan NV
10.8.1 Mylan NV Company Information
10.8.2 Mylan NV Description and Business Overview
10.8.3 Mylan NV End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mylan NV End Stage Renal Disease Drug Products Offered
10.8.5 Mylan NV Recent Development
10.9 Novartis AG
10.9.1 Novartis AG Company Information
10.9.2 Novartis AG Description and Business Overview
10.9.3 Novartis AG End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novartis AG End Stage Renal Disease Drug Products Offered
10.9.5 Novartis AG Recent Development
10.10 Lupin
10.10.1 Lupin Company Information
10.10.2 Lupin Description and Business Overview
10.10.3 Lupin End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Lupin End Stage Renal Disease Drug Products Offered
10.10.5 Lupin Recent Development
10.11 Cipla Inc
10.11.1 Cipla Inc Company Information
10.11.2 Cipla Inc Description and Business Overview
10.11.3 Cipla Inc End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Cipla Inc End Stage Renal Disease Drug Products Offered
10.11.5 Cipla Inc Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Description and Business Overview
10.12.3 Aurobindo Pharma End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Aurobindo Pharma End Stage Renal Disease Drug Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Fresenius SE & Co. KGaA
10.13.1 Fresenius SE & Co. KGaA Company Information
10.13.2 Fresenius SE & Co. KGaA Description and Business Overview
10.13.3 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Products Offered
10.13.5 Fresenius SE & Co. KGaA Recent Development
10.14 Sanofi
10.14.1 Sanofi Company Information
10.14.2 Sanofi Description and Business Overview
10.14.3 Sanofi End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sanofi End Stage Renal Disease Drug Products Offered
10.14.5 Sanofi Recent Development
10.15 Takeda Pharmaceutical Company Limited
10.15.1 Takeda Pharmaceutical Company Limited Company Information
10.15.2 Takeda Pharmaceutical Company Limited Description and Business Overview
10.15.3 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Products Offered
10.15.5 Takeda Pharmaceutical Company Limited Recent Development
10.16 F. Hoffmann-La Roche Ltd
10.16.1 F. Hoffmann-La Roche Ltd Company Information
10.16.2 F. Hoffmann-La Roche Ltd Description and Business Overview
10.16.3 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Products Offered
10.16.5 F. Hoffmann-La Roche Ltd Recent Development
10.17 Kissei Pharmaceutical Co., Ltd
10.17.1 Kissei Pharmaceutical Co., Ltd Company Information
10.17.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview
10.17.3 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Products Offered
10.17.5 Kissei Pharmaceutical Co., Ltd Recent Development
10.18 Abbott
10.18.1 Abbott Company Information
10.18.2 Abbott Description and Business Overview
10.18.3 Abbott End Stage Renal Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Abbott End Stage Renal Disease Drug Products Offered
10.18.5 Abbott Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 End Stage Renal Disease Drug Industry Chain Analysis
11.2 End Stage Renal Disease Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 End Stage Renal Disease Drug Production Mode & Process
11.4 End Stage Renal Disease Drug Sales and Marketing
11.4.1 End Stage Renal Disease Drug Sales Channels
11.4.2 End Stage Renal Disease Drug Distributors
11.5 End Stage Renal Disease Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. End Stage Renal Disease Drug CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. End Stage Renal Disease Drug Market Trends
Table 3. End Stage Renal Disease Drug Market Drivers
Table 4. End Stage Renal Disease Drug Market Challenges
Table 5. End Stage Renal Disease Drug Market Restraints
Table 6. Global End Stage Renal Disease Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India End Stage Renal Disease Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global End Stage Renal Disease Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India End Stage Renal Disease Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of End Stage Renal Disease Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global End Stage Renal Disease Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global End Stage Renal Disease Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global End Stage Renal Disease Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global End Stage Renal Disease Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global End Stage Renal Disease Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global End Stage Renal Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global End Stage Renal Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Drug as of 2024)
Table 18. Global Key Manufacturers of End Stage Renal Disease Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of End Stage Renal Disease Drug, Product Offered and Application
Table 20. Global Key Manufacturers of End Stage Renal Disease Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of End Stage Renal Disease Drug in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India End Stage Renal Disease Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India End Stage Renal Disease Drug Revenue Share by Players, (2018-2023)
Table 25. India End Stage Renal Disease Drug Sales by Players, (K Units), (2018-2023)
Table 26. India End Stage Renal Disease Drug Sales Share by Players, (2018-2023)
Table 27. Global End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global End Stage Renal Disease Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global End Stage Renal Disease Drug Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global End Stage Renal Disease Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global End Stage Renal Disease Drug Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas End Stage Renal Disease Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas End Stage Renal Disease Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas End Stage Renal Disease Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas End Stage Renal Disease Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA End Stage Renal Disease Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA End Stage Renal Disease Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA End Stage Renal Disease Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA End Stage Renal Disease Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC End Stage Renal Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC End Stage Renal Disease Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC End Stage Renal Disease Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC End Stage Renal Disease Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC End Stage Renal Disease Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Pfizer Inc Company Information
Table 48. Pfizer Inc Description and Business Overview
Table 49. Pfizer Inc End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Pfizer Inc End Stage Renal Disease Drug Product
Table 51. Pfizer Inc Recent Development
Table 52. AstraZeneca Company Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. AstraZeneca End Stage Renal Disease Drug Product
Table 56. AstraZeneca Recent Development
Table 57. Bristol-Myers Squibb Company Company Information
Table 58. Bristol-Myers Squibb Company Description and Business Overview
Table 59. Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Bristol-Myers Squibb Company End Stage Renal Disease Drug Product
Table 61. Bristol-Myers Squibb Company Recent Development
Table 62. Dr. Reddy's Laboratories Ltd Company Information
Table 63. Dr. Reddy's Laboratories Ltd Description and Business Overview
Table 64. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Product
Table 66. Dr. Reddy's Laboratories Ltd Recent Development
Table 67. Endo International plc Company Information
Table 68. Endo International plc Description and Business Overview
Table 69. Endo International plc End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Endo International plc End Stage Renal Disease Drug Product
Table 71. Endo International plc Recent Development
Table 72. Teva Pharmaceutical Industries Ltd Company Information
Table 73. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 74. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product
Table 76. Teva Pharmaceutical Industries Ltd Recent Development
Table 77. Sun Pharmaceutical Industries Ltd Company Information
Table 78. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 79. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product
Table 81. Sun Pharmaceutical Industries Ltd Recent Development
Table 82. Mylan NV Company Information
Table 83. Mylan NV Description and Business Overview
Table 84. Mylan NV End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Mylan NV End Stage Renal Disease Drug Product
Table 86. Mylan NV Recent Development
Table 87. Novartis AG Company Information
Table 88. Novartis AG Description and Business Overview
Table 89. Novartis AG End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Novartis AG End Stage Renal Disease Drug Product
Table 91. Novartis AG Recent Development
Table 92. Lupin Company Information
Table 93. Lupin Description and Business Overview
Table 94. Lupin End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Lupin End Stage Renal Disease Drug Product
Table 96. Lupin Recent Development
Table 97. Cipla Inc Company Information
Table 98. Cipla Inc Description and Business Overview
Table 99. Cipla Inc End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Cipla Inc End Stage Renal Disease Drug Product
Table 101. Cipla Inc Recent Development
Table 102. Aurobindo Pharma Company Information
Table 103. Aurobindo Pharma Description and Business Overview
Table 104. Aurobindo Pharma End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Aurobindo Pharma End Stage Renal Disease Drug Product
Table 106. Aurobindo Pharma Recent Development
Table 107. Fresenius SE & Co. KGaA Company Information
Table 108. Fresenius SE & Co. KGaA Description and Business Overview
Table 109. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Product
Table 111. Fresenius SE & Co. KGaA Recent Development
Table 112. Sanofi Company Information
Table 113. Sanofi Description and Business Overview
Table 114. Sanofi End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Sanofi End Stage Renal Disease Drug Product
Table 116. Sanofi Recent Development
Table 117. Takeda Pharmaceutical Company Limited Company Information
Table 118. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 119. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Product
Table 121. Takeda Pharmaceutical Company Limited Recent Development
Table 122. F. Hoffmann-La Roche Ltd Company Information
Table 123. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 124. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Product
Table 126. F. Hoffmann-La Roche Ltd Recent Development
Table 127. Kissei Pharmaceutical Co., Ltd Company Information
Table 128. Kissei Pharmaceutical Co., Ltd Description and Business Overview
Table 129. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Product
Table 131. Kissei Pharmaceutical Co., Ltd Recent Development
Table 132. Abbott Company Information
Table 133. Abbott Description and Business Overview
Table 134. Abbott End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Abbott End Stage Renal Disease Drug Product
Table 136. Abbott Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. End Stage Renal Disease Drug Customers List
Table 140. End Stage Renal Disease Drug Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. End Stage Renal Disease Drug Product Picture
Figure 2. Global End Stage Renal Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global End Stage Renal Disease Drug Market Size 2018-2034 (US$ Million)
Figure 4. Global End Stage Renal Disease Drug Sales 2018-2034 (K Units)
Figure 5. India End Stage Renal Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India End Stage Renal Disease Drug Market Size 2018-2034 (US$ Million)
Figure 7. India End Stage Renal Disease Drug Sales 2018-2034 (K Units)
Figure 8. India End Stage Renal Disease Drug Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India End Stage Renal Disease Drug Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. End Stage Renal Disease Drug Report Years Considered
Figure 11. Product Picture of Calcimimetics
Figure 12. Product Picture of Vitamin D
Figure 13. Product Picture of Sterols
Figure 14. Product Picture of Potassium Binders
Figure 15. Product Picture of Calcium-Based Phosphate Binders
Figure 16. Product Picture of Other
Figure 17. Global End Stage Renal Disease Drug Market Share by Type in 2024 & 2034
Figure 18. Global End Stage Renal Disease Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 19. Global End Stage Renal Disease Drug Sales Market Share in Value by Type (2018-2034)
Figure 20. Global End Stage Renal Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 21. Global End Stage Renal Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 22. Global End Stage Renal Disease Drug Price by Type (2018-2034) & (US$/Unit)
Figure 23. India End Stage Renal Disease Drug Market Share by Type in 2024 & 2034
Figure 24. India End Stage Renal Disease Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 25. India End Stage Renal Disease Drug Sales Market Share in Value by Type (2018-2034)
Figure 26. India End Stage Renal Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 27. India End Stage Renal Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 28. India End Stage Renal Disease Drug Price by Type (2018-2034) & (US$/Unit)
Figure 29. Product Picture of End Stage Renal Disease Induced Hyperparathyroidism
Figure 30. Product Picture of End Stage Renal Disease Induced Hyperphosphatemia
Figure 31. Product Picture of End Stage Renal Disease Induced Hyperkalaemia
Figure 32. Global End Stage Renal Disease Drug Market Share by Application in 2024 & 2034
Figure 33. Global End Stage Renal Disease Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 34. Global End Stage Renal Disease Drug Sales Market Share in Value by Application (2018-2034)
Figure 35. Global End Stage Renal Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 36. Global End Stage Renal Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 37. Global End Stage Renal Disease Drug Price by Application (2018-2034) & (US$/Unit)
Figure 38. India End Stage Renal Disease Drug Market Share by Application in 2024 & 2034
Figure 39. India End Stage Renal Disease Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 40. India End Stage Renal Disease Drug Sales Market Share in Value by Application (2018-2034)
Figure 41. India End Stage Renal Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 42. India End Stage Renal Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 43. India End Stage Renal Disease Drug Price by Application (2018-2034) & (US$/Unit)
Figure 44. Americas End Stage Renal Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 45. Americas End Stage Renal Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 46. Americas End Stage Renal Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 47. Americas End Stage Renal Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 48. Americas End Stage Renal Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 49. Americas End Stage Renal Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 50. United States End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Canada End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Mexico End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 54. EMEA End Stage Renal Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 55. EMEA End Stage Renal Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 56. EMEA End Stage Renal Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 57. EMEA End Stage Renal Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 58. EMEA End Stage Renal Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 59. EMEA End Stage Renal Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 60. Europe End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Middle East End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. Africa End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 63. China End Stage Renal Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 64. China End Stage Renal Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 65. China End Stage Renal Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 66. China End Stage Renal Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 67. China End Stage Renal Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 68. China End Stage Renal Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 69. APAC End Stage Renal Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 70. APAC End Stage Renal Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 71. APAC End Stage Renal Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 72. APAC End Stage Renal Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 73. APAC End Stage Renal Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 74. APAC End Stage Renal Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 75. Japan End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. South Korea End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. China Taiwan End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Southeast Asia End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. India End Stage Renal Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 80. End Stage Renal Disease Drug Value Chain
Figure 81. End Stage Renal Disease Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed